Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $123M (100.0% shares, 0.0% debt)

Holdings (26)

AGIO AGIOS PHARMACEUTICALS INC 12.1%
Value $14.92M Shares 282,443 Est. Cost $51.75 Unrealized -15.8%
SAGE THERAPEUTICS INC 9.9%
Value $12.27M Shares 266,500 Est. Cost $47.85 Unrealized
FOUNDATION MEDICINE INC 7.8%
Value $9.69M Shares 415,000 Est. Cost $19.35 Unrealized
EVH EVOLENT HEALTH INC 7.7%
Value $9.479M Shares 385,000 Est. Cost $17.38 Unrealized +34.5%
BLUEPRINT MEDICINES CORP 6.9%
Value $8.524M Shares 287,000 Est. Cost $26.00 Unrealized
LOXO ONCOLOGY INC 6.2%
Value $7.618M Shares 291,000 Est. Cost $27.57 Unrealized
GENMARK DIAGNOSTICS INC 6.0%
Value $7.375M Shares 625,000 Est. Cost $9.74 Unrealized
SPARK THERAPEUTICS INC 4.5%
Value $5.616M Shares 93,500 Est. Cost $42.99 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 4.5%
Value $5.532M Shares 240,000 Est. Cost $18.90 Unrealized
KITE PHARMA INC 4.1%
Value $5.027M Shares 90,000 Est. Cost $52.91 Unrealized
BLUEBIRD BIO INC 3.3%
Value $4.067M Shares 60,000 Est. Cost $60.25 Unrealized
CLOVIS ONCOLOGY INC 3.2%
Value $3.966M Shares 110,000 Est. Cost $13.72 Unrealized
VYGR VOYAGER THERAPEUTICS INC 2.7%
Value $3.321M Shares 276,500 Est. Cost $17.92 Unrealized
EPIZYME INC 2.4%
Value $2.903M Shares 295,000 Est. Cost $14.50 Unrealized
EXAS EXACT SCIENCES CORP 2.3%
Value $2.878M Shares 155,000 Est. Cost $17.62 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 2.1%
Value $2.643M Shares 39,000 Est. Cost $83.97 Unrealized -16.0%
MDRX ALLSCRIPTS HEALTHCARE SOLUTN 2.1%
Value $2.634M Shares 200,000 Est. Cost $13.37 Unrealized 0.0%
MYOKARDIA INC 2.1%
Value $2.614M Shares 160,000 Est. Cost $14.07 Unrealized
GENOMIC HEALTH INC 2.1%
Value $2.603M Shares 90,000 Est. Cost $28.92 Unrealized
MEDGENICS INC 1.7%
Value $2.089M Shares 375,000 Est. Cost $5.57 Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.6%
Value $1.999M Shares 127,500 Est. Cost $15.82 Unrealized -23.5%
IBB ISHARES TR 1.2%
Value $1.447M Shares 5,000 Est. Cost $289.40 Unrealized
IGNYTA INC 1.0%
Value $1.227M Shares 195,000 Est. Cost $5.82 Unrealized
IONS IONIS PHARMACEUTICALS INC 1.0%
Value $1.209M Shares 33,000 Est. Cost $31.29 Unrealized 0.0%
EDIT EDITAS MEDICINE INC 0.9%
Value $1.152M Shares 85,470 Est. Cost $20.49 Unrealized 0.0%
SYROS PHARMACEUTICALS INC 0.6%
Value $694K Shares 50,000 Est. Cost $18.16 Unrealized